Delivery Order SPE2DB24D1205-SPE2DB25FCWNV
Award Date
5/7/25
Potential Completion Date
5/8/25
Potential Value
$3.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Olmesartan Medoxomil 40 mg tablets in 90-count packages, with a ceiling value of $5,672.29. It is a firm-fixed-price contract with an ultimate completion date of April 16, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,210.58, is for the delivery of Olmesartan Medoxomil 40 mg tablets in 90-count packages. The contract type is firm fixed price, and the ultimate completion date is February 26, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Olmesartan Medoxomil 40 mg tablets in 90-count packages, with a ceiling value of $7,189.33 and a period of performance through April 2025. The contract is a firm-fixed-price delivery order and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,877.34, is for the supply of Olmesartan Medoxomil 40 mg tablets in 30-count packages. The contract has a period of performance through January 3, 2025 and utilizes a Firm Fixed Price pricing type. This award is associated with Amerisourcebergen's larger Indefinite...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $8,382.90, is for the supply of Olmesartan Medoxomil 40 mg tablets to support military healthcare programs. The contract is a firm fixed-price, delivery order type with an ultimate completion date of January 5, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Olmesartan Medoxomil 40 mg tablets. The contract has a ceiling value of $2,275.38 and a completion date of February 7, 2025. The contract is a firm fixed-price delivery order, and there is no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,113.18, is for the delivery of Olmesartan Medoxomil 40 mg tablets in 90-count packages. The contract has an ultimate completion date of April 15, 2025. This appears to be a delivery order contract, with a firm fixed price pricing type. The contract is not designated as a set-aside....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the delivery of Olmesartan Medoxomil 40 mg tablets, a medication used to treat hypertension. The contract has a ceiling value of $1,094.27 and an ultimate completion date of August 26, 2024. It is a firm-fixed-price contract, with no set-aside designation indicated. AmerisourceBergen holds a larger Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,467.58, is for the delivery of Olmesartan Medoxomil 40 mg tablets. The contract is a Firm Fixed Price delivery order with an ultimate completion date of December 10, 2024. This award is not associated with a set-aside program. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $4,703.88, is for the delivery of Olmesartan Medoxomil 40 mg tablets. The contract has an ultimate completion date of April 16, 2025 and was awarded on April 15, 2025. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA...